Market Tracker

12/19 6:05pm ET

PDL BioPharma Inc (NASDAQ:PDLI)

7.74
Data as of Dec 19
 -0.16 / -2.03%
Today’s Change
7.22
Today|||52-Week Range
10.26
-8.29%
Year-to-Date

Today’s Trading

Previous close7.90
Today’s open7.88
Day’s range7.73 - 7.97
Volume5,370,731
Average volume (3 months)2,885,953
Market cap$1.2B
Dividend yield7.75%
Data as of 3:59pm ET, 12/19/2014

Growth & Valuation

Earnings growth (last year)+14.48%
Earnings growth (this year)+28.31%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+18.26%
P/E ratio4.0
Price/Sales2.66
Price/Book9.54

Competitors

 Today’s
change
Today’s
% change
KPTIKaryopharm Therapeut...+2.43+6.73%
USNAUSANA Health Science...-0.34-0.33%
MACKMerrimack Pharmaceut...+0.62+5.95%
TTPHTetraphase Pharmaceu...-0.52-1.37%
Data as of 4:06pm ET, 12/19/2014

Financials

Next reporting dateMarch 2, 2015
EPS forecast (this quarter)$0.56
Annual revenue (last year)$442.9M
Annual profit (last year)$264.5M
Net profit margin59.72%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Peter McLaughlin
Chief Financial Officer &
Vice President
Peter S. Garcia
Corporate headquarters
Incline Village, Nevada

Forecasts